metoprolol succinate

Generic: metoprolol succinate

Labeler: nivagen pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name metoprolol succinate
Generic Name metoprolol succinate
Labeler nivagen pharmaceuticals, inc.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

metoprolol succinate 200 mg/1

Manufacturer
Nivagen Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 75834-293
Product ID 75834-293_01740be9-3731-2dd7-e063-6294a90a2b7a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203699
Listing Expiration 2026-12-31
Marketing Start 2021-02-26

Pharmacologic Class

Classes
adrenergic beta-antagonists [moa] beta-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 75834293
Hyphenated Format 75834-293

Supplemental Identifiers

RxCUI
866412 866419
UPC
0375834293011 0375834292014 0375834292007 0375834292052 0375834293059 0375834293004
UNII
TH25PD4CCB

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name metoprolol succinate (source: ndc)
Generic Name metoprolol succinate (source: ndc)
Application Number ANDA203699 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/1
source: ndc
Packaging
  • 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-293-00)
  • 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-293-01)
  • 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-293-05)
source: ndc

Packages (3)

75834-293-00 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-293-00) 75834-293-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-293-01) 75834-293-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-293-05)

Ingredients (1)

metoprolol succinate (200 mg/1)

Linked Drug Pages (1)

Metoprolol Succinate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "01740be9-3731-2dd7-e063-6294a90a2b7a", "openfda": {"upc": ["0375834293011", "0375834292014", "0375834292007", "0375834292052", "0375834293059", "0375834293004"], "unii": ["TH25PD4CCB"], "rxcui": ["866412", "866419"], "spl_set_id": ["da7a72f9-2246-6934-e053-2995a90a6376"], "manufacturer_name": ["Nivagen Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-293-00)", "package_ndc": "75834-293-00", "marketing_start_date": "20220223"}, {"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-293-01)", "package_ndc": "75834-293-01", "marketing_start_date": "20220223"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-293-05)", "package_ndc": "75834-293-05", "marketing_start_date": "20220223"}], "brand_name": "Metoprolol Succinate", "product_id": "75834-293_01740be9-3731-2dd7-e063-6294a90a2b7a", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Adrenergic beta-Antagonists [MoA]", "beta-Adrenergic Blocker [EPC]"], "product_ndc": "75834-293", "generic_name": "Metoprolol Succinate", "labeler_name": "Nivagen Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Metoprolol Succinate", "active_ingredients": [{"name": "METOPROLOL SUCCINATE", "strength": "200 mg/1"}], "application_number": "ANDA203699", "marketing_category": "ANDA", "marketing_start_date": "20210226", "listing_expiration_date": "20261231"}